Which has higher earnings & valuation, WAY or SDGR?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.32 $112.09M $0.70 35.40 Schrodinger $255.87M 5.07 -$103.26M -$0.74 N/A

Is WAY or SDGR more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Schrodinger -20.98% -16.37% -8.19%

Does the media favor WAY or SDGR?

In the previous week, Waystar and Waystar both had 9 articles in the media. Waystar's average media sentiment score of 0.77 beat Schrodinger's score of 0.75 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, SDGR or DOCS?

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 5.07 -$103.26M -$0.74 N/A Doximity $644.86M 6.87 $196.05M $0.85 29.25

Is SDGR or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Doximity 25.48% 18.06% 15.40%

Does the media prefer SDGR or DOCS?

In the previous week, Doximity had 10 more articles in the media than Schrodinger. MarketBeat recorded 19 mentions for Doximity and 9 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.75 beat Doximity's score of 0.58 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, HTFL or SDGR?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 20.62 -$116.79M -$3.11 N/A Schrodinger $255.87M 5.07 -$103.26M -$0.74 N/A

Is HTFL or SDGR more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.50% -18.51% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer HTFL or SDGR?

In the previous week, Heartflow had 12 more articles in the media than Schrodinger. MarketBeat recorded 21 mentions for Heartflow and 9 mentions for Schrodinger. Heartflow's average media sentiment score of 0.91 beat Schrodinger's score of 0.75 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 10 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, CERT or SDGR?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 2.91 -$1.60M -$0.45 N/A Schrodinger $255.87M 5.07 -$103.26M -$0.74 N/A

Is CERT or SDGR more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Schrodinger -20.98% -16.37% -8.19%

Does the media favor CERT or SDGR?

In the previous week, Schrodinger had 4 more articles in the media than Certara. MarketBeat recorded 9 mentions for Schrodinger and 5 mentions for Certara. Certara's average media sentiment score of 1.24 beat Schrodinger's score of 0.75 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TDOC or SDGR?

In the previous week, Schrodinger had 1 more articles in the media than Teladoc Health. MarketBeat recorded 9 mentions for Schrodinger and 8 mentions for Teladoc Health. Schrodinger's average media sentiment score of 0.75 beat Teladoc Health's score of 0.27 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 1 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Schrodinger (SDGR) Competitors

$17.59 -0.87 (-4.71%)

Closing price 04:00 PM Eastern

Extended Trading

$17.60 +0.02 (+0.09%)

As of 07:48 PM Eastern

Compare

SDGR vs. WAY, DOCS, HTFL, CERT, and TDOC

Should you buy Schrodinger stock or one of its competitors? Schrodinger's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Heartflow (HTFL), Certara (CERT), and Teladoc Health (TDOC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Schrodinger compare to Waystar?

Waystar (NASDAQ:WAY) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Waystar currently has a consensus target price of $35.00, suggesting a potential upside of 41.24%. Schrodinger has a consensus target price of $20.43, suggesting a potential upside of 16.14%. Given Waystar's stronger consensus rating and higher probable upside, equities analysts plainly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	1 Sell rating(s)	2 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.96
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.32	$112.09M	$0.70	35.40
Schrodinger	$255.87M	5.07	-$103.26M	-$0.74	N/A

In the previous week, Waystar and Waystar both had 9 articles in the media. Waystar's average media sentiment score of 0.77 beat Schrodinger's score of 0.75 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

79.1% of Schrodinger shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Waystar has a beta of 0.06, suggesting that its share price is 94% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Schrodinger	-20.98%	-16.37%	-8.19%

Summary

Waystar beats Schrodinger on 12 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Doximity?

Schrodinger (NASDAQ:SDGR) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 31.8% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Schrodinger presently has a consensus price target of $20.43, indicating a potential upside of 16.14%. Doximity has a consensus price target of $32.10, indicating a potential upside of 29.10%. Given Doximity's stronger consensus rating and higher possible upside, analysts plainly believe Doximity is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Doximity	4 Sell rating(s)	12 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.28

Doximity has a net margin of 25.48% compared to Schrodinger's net margin of -20.98%. Doximity's return on equity of 18.06% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Doximity	25.48%	18.06%	15.40%

Doximity has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.07	-$103.26M	-$0.74	N/A
Doximity	$644.86M	6.87	$196.05M	$0.85	29.25

In the previous week, Doximity had 10 more articles in the media than Schrodinger. MarketBeat recorded 19 mentions for Doximity and 9 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.75 beat Doximity's score of 0.58 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, Doximity has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

Summary

Doximity beats Schrodinger on 15 of the 17 factors compared between the two stocks.

How does Schrodinger compare to Heartflow?

Heartflow (NASDAQ:HTFL) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

Heartflow presently has a consensus target price of $43.43, indicating a potential upside of 3.20%. Schrodinger has a consensus target price of $20.43, indicating a potential upside of 16.14%. Given Schrodinger's higher possible upside, analysts plainly believe Schrodinger is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	20.62	-$116.79M	-$3.11	N/A
Schrodinger	$255.87M	5.07	-$103.26M	-$0.74	N/A

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.50%	-18.51%
Schrodinger	-20.98%	-16.37%	-8.19%

79.1% of Schrodinger shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Heartflow had 12 more articles in the media than Schrodinger. MarketBeat recorded 21 mentions for Heartflow and 9 mentions for Schrodinger. Heartflow's average media sentiment score of 0.91 beat Schrodinger's score of 0.75 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	10 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Schrodinger beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Schrodinger compare to Certara?

Certara (NASDAQ:CERT) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	2.91	-$1.60M	-$0.45	N/A
Schrodinger	$255.87M	5.07	-$103.26M	-$0.74	N/A

In the previous week, Schrodinger had 4 more articles in the media than Certara. MarketBeat recorded 9 mentions for Schrodinger and 5 mentions for Certara. Certara's average media sentiment score of 1.24 beat Schrodinger's score of 0.75 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara presently has a consensus target price of $8.28, indicating a potential upside of 3.47%. Schrodinger has a consensus target price of $20.43, indicating a potential upside of 16.14%. Given Schrodinger's higher possible upside, analysts clearly believe Schrodinger is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

74.0% of Certara shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Schrodinger	-20.98%	-16.37%	-8.19%

Certara has a beta of 1.44, indicating that its stock price is 44% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market.

Summary

Certara beats Schrodinger on 11 of the 17 factors compared between the two stocks.

How does Schrodinger compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Teladoc Health has a net margin of -7.13% compared to Schrodinger's net margin of -20.98%. Teladoc Health's return on equity of -12.15% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
Schrodinger	-20.98%	-16.37%	-8.19%

Teladoc Health currently has a consensus price target of $7.54, suggesting a potential upside of 10.43%. Schrodinger has a consensus price target of $20.43, suggesting a potential upside of 16.14%. Given Schrodinger's higher probable upside, analysts plainly believe Schrodinger is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
Schrodinger	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Schrodinger has lower revenue, but higher earnings than Teladoc Health. Schrodinger is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.49	-$200.32M	-$0.99	N/A
Schrodinger	$255.87M	5.07	-$103.26M	-$0.74	N/A

In the previous week, Schrodinger had 1 more articles in the media than Teladoc Health. MarketBeat recorded 9 mentions for Schrodinger and 8 mentions for Teladoc Health. Schrodinger's average media sentiment score of 0.75 beat Teladoc Health's score of 0.27 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	1 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	3 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teladoc Health has a beta of 2.12, meaning that its stock price is 112% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market.

Summary

Schrodinger beats Teladoc Health on 8 of the 15 factors compared between the two stocks.

Get Schrodinger News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SDGR vs. The Competition

Export

Metric	Schrodinger	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.36B	$1.62B	$7.06B	$13.10B
Dividend Yield	N/A	4.69%	2.57%	10.45%
P/E Ratio	-23.77	24.17	269.06	25.28
Price / Sales	5.07	72.88	602.43	91.76
Price / Cash	N/A	30.75	70.48	50.90
Price / Book	3.94	6.52	12.91	6.24
Net Income	-$103.26M	-$25.90M	$3.45B	$347.60M
7 Day Performance	-3.14%	3.06%	1.12%	1.07%
1 Month Performance	9.05%	5.27%	1.79%	1.03%
1 Year Performance	-9.56%	-15.58%	67.69%	20.77%

Schrodinger Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SDGR Schrodinger	1.6239 of 5 stars	$17.59 -4.7%	$20.43 +16.1%	-7.0%	$1.36B	$255.87M	N/A	790	Analyst Downgrade
WAY Waystar	4.4495 of 5 stars	$22.66 +7.3%	$35.14 +55.1%	-29.1%	$4.05B	$1.10B	32.37	1,700	Analyst Upgrade Insider Trade Gap Up
DOCS Doximity	4.2587 of 5 stars	$21.72 +3.9%	$29.33 +35.0%	N/A	$3.82B	$644.86M	21.94	890	Analyst Forecast Insider Trade
HTFL Heartflow	1.8475 of 5 stars	$26.76 +6.1%	$36.57 +36.7%	N/A	$2.18B	$176.03M	N/A	699	Trending News Earnings Report Analyst Forecast Insider Trade Gap Up
CERT Certara	2.0004 of 5 stars	$8.18 +1.0%	$8.85 +8.2%	-27.0%	$1.26B	$418.84M	N/A	1,576

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SDGR) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Schrodinger (SDGR) Competitors

SDGR vs. WAY, DOCS, HTFL, CERT, and TDOC

How does Schrodinger compare to Waystar?

Summary

How does Schrodinger compare to Doximity?

Summary

How does Schrodinger compare to Heartflow?

Summary

How does Schrodinger compare to Certara?

Summary

How does Schrodinger compare to Teladoc Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Schrodinger (SDGR) Competitors

SDGR vs. WAY, DOCS, HTFL, CERT, and TDOC

How does Schrodinger compare to Waystar?

Do analysts prefer WAY or SDGR?

Which has higher earnings & valuation, WAY or SDGR?

Does the media favor WAY or SDGR?

Do institutionals & insiders hold more shares of WAY or SDGR?

Which has more volatility and risk, WAY or SDGR?

Is WAY or SDGR more profitable?

Summary

How does Schrodinger compare to Doximity?

Do institutionals and insiders have more ownership in SDGR or DOCS?

Do analysts recommend SDGR or DOCS?

Is SDGR or DOCS more profitable?

Which has higher earnings and valuation, SDGR or DOCS?

Does the media prefer SDGR or DOCS?

Which has more volatility and risk, SDGR or DOCS?

Summary

How does Schrodinger compare to Heartflow?

Do analysts recommend HTFL or SDGR?

Which has higher valuation and earnings, HTFL or SDGR?

Is HTFL or SDGR more profitable?

Do institutionals & insiders have more ownership in HTFL or SDGR?

Does the media prefer HTFL or SDGR?

Summary

How does Schrodinger compare to Certara?

Which has better valuation and earnings, CERT or SDGR?

Does the media favor CERT or SDGR?

Do analysts recommend CERT or SDGR?

Do institutionals and insiders believe in CERT or SDGR?

Is CERT or SDGR more profitable?

Which has more risk and volatility, CERT or SDGR?

Summary

How does Schrodinger compare to Teladoc Health?

Is TDOC or SDGR more profitable?

Do analysts rate TDOC or SDGR?

Do institutionals & insiders hold more shares of TDOC or SDGR?

Which has preferable valuation & earnings, TDOC or SDGR?

Does the media refer more to TDOC or SDGR?

Which has more risk and volatility, TDOC or SDGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SDGR vs. The Competition

Schrodinger Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools